ABC News - Breaking News, Latest News and Videos·3 min read·medium
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Y
Youri Benadjaoud
✦AI Summary
Moderna has launched a Phase 1 clinical trial for an mRNA-based vaccine targeting the Bundibugyo strain of Ebola, which is currently causing an outbreak in the DRC. The trial is being conducted in Canada with funding support from the Coalition for Epidemic Preparedness Innovations.
Moderna has begun a Phase 1 clinical trial of an Ebola vaccine set to target the Bundibugyo strain, which is currently circulating in the eastern Democratic Republic of the Congo (DRC), the pharmaceutical company announced Tuesday.
healthsciencetechnology
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in